4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049664
SVP & Chief Medical Officer sold 1,997 shares at $19.32 ($38,582)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gergel Ivan P. SVP & Chief Medical Officer | 2017-08-16 | Sale | −1,997 | $19.32 | $38,582 | 41,575 | D: show line 1 in the form |
| Open-market sales · 1,997 sh · avg $19.32 · $38,582 | |||||||
Loading xslF345X03/doc4.xml…